Advertisement

Topics

FortuneRock (China) Co., Ltd. Company Profile

10:10 EDT 21st September 2018 | BioPortfolio

FortuneRock (China) Co., Ltd., a biotechnology and biopharmaceutical company registered in Beijing. Along with its 3 subsidiaries, Tianjin SinoBiotech Ltd., SinoBiotech (Tianjin) Ltd. and Beijing Bio-Fortune Ltd., the group is focused on the discovery, development, and commercialization of novel, patent-protected gene-based recombinant protein drugs with high clinical value for the treatment of life-threatening and debilitating diseases. Currently, the company has one drug with clinical Phase I completed, one in later stage clinical Phase II, another waiting for approval to enter into clinical trials, and several novel drugs in pre-clinical studies, all for different indications.


News Articles [1719 Associated News Articles listed on BioPortfolio]

China Mobile Develops Roadside Units for LTE-V2X PC5 Direct Communication Featuring Qualcomm ...

WUXI, China, Sept. 15, 2018 /PRNewswire/ -- China Mobile Research Institute, China Mobile IoT (CMIoT) Company Limited, a wholly-owned subsidiary of China Mobile, and Qualcomm Read more...

China’s Emergence Into the Global Pharma Industry

Recently big pharma have been taking advantage of the financial and industrial environment in China. In this interview Fintan Walton and Dr. Bill Guo, founder and Chairman of Venturepharm, take a look...

China, the South China Sea and North Korea

The United States needs to diplomatically engage China over the South China Sea to reduce tensions, build trust, and achieve a quick and lasting solution to the North Korea problem. The USS Carl Vins...

AmCham South China Delegation to Boost US-China Economic and Trade Cooperation at its Sixteenth ...

XIAMEN, China, Sept. 7, 2018 /PRNewswire/ -- The award-winning American Chamber of Commerce in South China (AmCham South China) delegation, led by the Chamber's President Read more...

BMS to Set China Price of Opdivo, a PD-1 Drug, at 50% of US Cost

Bristol-Myers Squibb will set the China price of Opdivo, its PD-1 lung cancer treatment, at half the US price, according to news sources. The US price is roughly $150,000, but the China price will be ...

Hutchison China MediTech (HCM) - Fruquintinib capsules approved in China

Edison Investment Research - Pharmaceutical & healthcare - Hutchison China MediTech: Hutchison China MediTech’s (HCM) lead TKI asset, fruquintinib, has received China registration approval from ...

China OKs Chi-Med's metastatic colorectal cancer therapy

China's National Medical Products Administration granted approval to Hutchison China MediTech's Elunate, or fruquintinib.  -More- 

General says China needs to arm South China Sea islands

BEIJING (AP) — China needs to build defensive structures on islands in the South China Sea to display its claim to sovereignty over virtually the entire crucial waterway, a leading Chinese general s...

PubMed Articles [1077 Associated PubMed Articles listed on BioPortfolio]

Comparison of ARIMA and GM(1,1) models for prediction of hepatitis B in China.

Hepatitis B virus (HBV) infection is a major public health threat in China for China has a hepatitis B prevalence of more than one million people in 2017 year. Disease incidence prediction may help he...

HIV epidemics in Shenzhen and Chongqing, China.

Men who have sex with men (MSM) and heterosexuals are the populations with the fastest growing HIV infection rates in China. We characterize the epidemic growth and age patterns between these two rout...

High relative risk of all-cause mortality attributed to smoking in China: Guangzhou Biobank Cohort Study.

Prediction of disease burden in China arising from smoking based on earlier cohorts in the West and China could not reflect the disease burden at the current stage accurately. No cohort studies in Chi...

Emission Characteristics of Particulate Matter from Diesel Buses Meeting Different China Emission Standards Fueled with Biodiesel.

Based on heavy chassis dynamometer, an experimental study was conducted in diesel buses compliant with China Ⅲ,Ⅳ,Ⅴ emissions standards respectively, fueled with three different blends of petrole...

Health impact of China's Air Pollution Prevention and Control Action Plan: an analysis of national air quality monitoring and mortality data.

To mitigate the serious levels of air pollution in China, the State Council of China issued the Air Pollution Prevention and Control Action Plan (APPCAP) in 2013. This policy is a milestone in air qua...

Clinical Trials [860 Associated Clinical Trials listed on BioPortfolio]

SYNERGY China: Assess SYNERGY Stent in China

Prospective, multicenter, single-arm study, enroll 100 patients in no more than 10 sites across China, the primary endpoint is Technical success.

Trevo® Retriever Registry (China)

Trevo® Retriever Registry (China) is to assess real world performance of the SDA cleared Trevo Retriever intended to restore blood flow in the neurovasculature by removing thrombus in pat...

China PEACE Millions Persons Project

China PEACE Millions Persons Project is a national screening project for cardiovascular disease in China. This Project was approved by National Health and Family Planning Commission (NHFPC...

Study of China Heart Failure Registry to Investigate Characteristics of Patients in China

The purpose of this study is to assess clinical characteristics, treatment, and outcome of patients hospitalized with heart failure in China and compared those with other registries

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

In a hospital-based multi-center study in China, HPV 16 was found to be the predominant type (72.9%) in cervical cancer, followed by HPV 18(8.0%) which indicated that if the HPV prophylact...

Companies [527 Associated Companies listed on BioPortfolio]

FortuneRock (China) Co., Ltd.

FortuneRock (China) Co., Ltd., a biotechnology and biopharmaceutical company registered in Beijing. Along with its 3 subsidiaries, Tianjin SinoBiotech Ltd., SinoBiotech (Tianjin) ...

FortuneRock (China) Ltd.

FortuneRock (China) Ltd., a privately held biotechnology and biopharmaceutical company registered in Beijing. Along with its 3 wholly owned subsidiaries, Tianjin SinoBiotech Ltd.,...

China Business Solutions Ltd

China Business Solutions provides a one-stop consulting and research service to British companies doing or wishing to do business in China. With China's economy continuing to grow at 9% year on year, ...

eChinaChem

eChinaChem, Inc., the China subsidiary of Pacific Genuity, Inc. (San Carlos, California), provides an integrated end-to-end solution for international chemical trading with China. Our company offers ...

China Kangtai Cactus Bio-tech, Inc.

China Kangtai Cactus Bio-tech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy...

More Information about "FortuneRock (China) Co., Ltd." on BioPortfolio

We have published hundreds of FortuneRock (China) Co., Ltd. news stories on BioPortfolio along with dozens of FortuneRock (China) Co., Ltd. Clinical Trials and PubMed Articles about FortuneRock (China) Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FortuneRock (China) Co., Ltd. Companies in our database. You can also find out about relevant FortuneRock (China) Co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record